Licensing agreement deals decline in rare diseases space, says report
New research has shown that complex collaborations and partnerships are increasing, while licensing agreements are decreasing in the rare disease space.
List view / Grid view
New research has shown that complex collaborations and partnerships are increasing, while licensing agreements are decreasing in the rare disease space.
18 June 2015 | By Victoria White
Galapagos has completed recruitment for the Phase 2 Proof-of-Concept study in ulcerative colitis with GPR84 inhibitor GLPG1205...